Ryanair
RYAAY
56.00
+0.14
+0.24%
Ryanair
US · RYAAY
#708 by market cap
Listed 1970
56.00
+0.14
+0.24%
Live - 5344 symbols - heartbeat 305s ago
· 2026-10-08 05:49
Pre-market
54.27
-3.09%
After-hours
56.00
0.00%
Overnight
54.68
-2.36%
- Market cap
- 29.00B
- P/E (TTM)i
- 13.99
- P/Bi
- 2.73
- EPSi
- 4.57
- Div yieldi
- 1.71%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on RYAAY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.42, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.44% YoY
Margins
- Gross margin
- 22.58%
- Operating margin
- 15.27%
- Net margin
- 13.98%
Key ratios & quality
- Enterprise valuei
- 26.84B
- PEG ratioi
- 0.77
- Altman Z-Scorei
- 3.42
PEG uses trailing P/E against the 3-year net income growth rate (18.27%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.70B | 8.49B | 1.64B | 4.80B | 10.78B | 13.44B | 13.95B | 15.54B |
| Gross profit | 1.62B | 1.77B | -604.10M | 120.70M | 2.22B | 2.98B | 2.65B | 3.51B |
| Selling & admin expenses | 602.10M | 646.30M | 235.30M | 460.30M | 780.40M | 921.80M | 1.09B | 1.14B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.02B | 1.13B | -839.40M | -339.60M | 1.44B | 2.06B | 1.56B | 2.37B |
| Pretax profit | 948.10M | 670.30M | -1.11B | -429.80M | 1.44B | 2.13B | 1.78B | 2.42B |
| Tax | 63.10M | 21.60M | -93.60M | -189.00M | 128.70M | 210.90M | 172.80M | 249.60M |
| Net profit | 885.00M | 648.70M | -1.02B | -240.80M | 1.31B | 1.92B | 1.61B | 2.17B |
| Basic EPS | 2 | 1 | -2 | 0 | 2 | 3 | 3 | 4 |
| Diluted EPS | 1.53 | 1.16 | -1.83 | -0.43 | 2.31 | 3.35 | 2.91 | 4.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.30B | 4.34B | 5.48B | 3.21B | 2.51B | 4.38B |
| Gross profit | -99.20M | 1.13B | 2.16B | 277.20M | -66.30M | 778.40M |
| Selling & admin expenses | 389.90M | 221.20M | 217.40M | 174.00M | 523.20M | 203.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -489.10M | 913.30M | 1.95B | 103.20M | -589.50M | 575.40M |
| Pretax profit | -426.20M | 930.20M | 1.96B | 24.40M | -492.70M | 592.90M |
| Tax | -98.00M | 110.30M | 242.50M | -6.00M | -97.20M | 55.20M |
| Net profit | -328.20M | 819.90M | 1.72B | 30.40M | -395.50M | 537.70M |
| Basic EPS | -1 | 2 | 3 | 0 | -1 | 1 |
| Diluted EPS | -0.57 | 1.53 | 3.22 | 0.06 | -0.74 | 1.02 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.80B | 4.49B | 3.46B | 5.48B | 5.91B | 5.83B | 6.01B | 7.74B |
| Cash & ST investments | 3.16B | 3.77B | 3.12B | 3.60B | 4.66B | 4.11B | 3.96B | 3.55B |
| Inventory | 2.90M | 3.30M | 3.60M | 4.30M | 6.00M | 6.20M | 4.60M | 4.80M |
| Total assets | 13.25B | 14.75B | 12.33B | 15.15B | 16.41B | 17.18B | 17.51B | 19.75B |
| Total current liabilities | 4.10B | 5.51B | 3.53B | 5.40B | 7.42B | 6.40B | 8.15B | 8.57B |
| Short-term debt | 309.40M | 457.30M | 1.78B | 1.28B | 1.10B | 89.40M | 886.10M | 1.24B |
| Long-term debt | 3.34B | 3.58B | 3.52B | 3.71B | 2.85B | 2.53B | 1.69B | 147.80M |
| Total liabilities | 8,035,800,000.00 | 9,832,700,000.00 | 7,681,400,000.00 | 9,604,500,000.00 | 10,762,900,000.00 | 9,561,400,000.00 | 10,470,100,000.00 | 9,646,300,000.00 |
| Total equity | 5.21B | 4.91B | 4.65B | 5.55B | 5.64B | 7.61B | 7.04B | 10.10B |
| Retained earnings | 4.18B | 4.25B | 3.23B | 2.88B | 4.18B | 5.90B | 5.59B | 6.78B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.01B | 6.47B | 4.71B | 4.30B | 7.74B | 6.20B |
| Cash & ST investments | 3.96B | 4.35B | 2.96B | 2.39B | 3.55B | 2.80B |
| Inventory | 4.60M | 5.00M | 5.30M | 5.30M | 4.80M | 4.60M |
| Total assets | 17.51B | 18.08B | 16.39B | 16.04B | 19.75B | 18.16B |
| Total current liabilities | 8.15B | 9.80B | 6.60B | 6.46B | 8.57B | 7.85B |
| Short-term debt | 886.10M | 2.08B | 1.23B | 1.23B | 1.24B | 39.80M |
| Long-term debt | 1.69B | 147.30M | 147.40M | 147.60M | 147.80M | 38.30M |
| Total liabilities | 10,470,100,000.00 | 10,675,200,000.00 | 7,419,300,000.00 | 7,262,700,000.00 | 9,646,300,000.00 | 8,682,800,000.00 |
| Total equity | 7.04B | 7.40B | 8.97B | 8.78B | 10.10B | 9.48B |
| Retained earnings | 5.59B | 6.34B | 7.68B | 7.55B | 6.78B | 7.15B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.76B | 1.33B | -2.45B | 1.94B | 3.89B | 3.16B | 3.42B | 3.69B |
| Depreciation & amortization | 640.50M | 748.70M | 571.00M | 719.40M | 923.20M | 1.06B | 1.21B | 1.37B |
| Free cash flow | 470.80M | 748.30M | -2.74B | 758.90M | 1.98B | 766.00M | 1.86B | 1.80B |
| Dividends paid | -- | -- | -- | 0 | 0 | -199.50M | -437.70M | -443.30M |
| Stock buybacks / issuance | -531.60M | -561.40M | 421.00M | 46.80M | 31.70M | 16.40M | -1.47B | -533.30M |
| Ending cash balance | 1.68B | 2.57B | 2.65B | 2.67B | 3.60B | 3.88B | 3.86B | 2.73B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.32B | 1.46B | 320.90M | -72.80M | 1.99B | 1.20B |
| Depreciation & amortization | 295.10M | 343.30M | 344.20M | 326.40M | 359.50M | 417.10M |
| Free cash flow | 1.86B | 835.40M | -169.60M | -396.70M | 1.53B | 728.70M |
| Dividends paid | -240.40M | -- | -- | -11.70M | -202.60M | -- |
| Stock buybacks / issuance | -364.70M | -58.10M | -142.70M | -159.10M | -173.40M | -153.40M |
| Ending cash balance | 3.86B | 3.61B | 2.96B | 2.39B | 2.73B | 2.48B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.28 | 12.81 | -21.23 | -4.73 | 23.49 | 28.92 | 22.00 | 25.37 |
| ROA %i | 6.91 | 4.63 | -7.50 | -1.75 | 8.33 | 11.42 | 9.29 | 11.67 |
| ROIC %i | 10.83 | 7.77 | -10.06 | -1.55 | 13.20 | 18.50 | 14.04 | 19.73 |
| 5-year avg ROE %i | 29.65 | 27.48 | 15.06 | 7.55 | 5.72 | 7.85 | 9.69 | 19.01 |
| EBIT margin %i | 13.08 | 8.75 | -63.51 | -7.05 | 14.10 | 16.45 | 13.27 | 15.83 |
| FCF / sales %i | 6.12 | 8.81 | -- | 15.81 | 18.34 | 5.70 | 13.36 | 11.60 |
| Current ratioi | 0.93 | 0.82 | 0.98 | 1.01 | 0.80 | 0.91 | 0.74 | 0.90 |
| Quick ratioi | 0.79 | 0.71 | 0.89 | 0.68 | 0.64 | 0.65 | 0.50 | 0.42 |
| Debt / assetsi | 27.50 | 28.56 | 44.02 | 33.51 | 25.09 | 15.99 | 15.32 | 7.55 |
| LT debt / equityi | 63.95 | 76.38 | 78.52 | 68.45 | 53.45 | 34.90 | 25.53 | 2.50 |
| Interest coveragei | 17.04 | 10.19 | -14.88 | -3.70 | 19.78 | 26.64 | 27.83 | 65.11 |
| Revenue CAGR (3Y) %i | 5.60 | 8.52 | -38.84 | -14.56 | 8.25 | 101.80 | 42.69 | 12.99 |
| Net income CAGR (3Y) %i | -17.20 | -21.00 | -- | -- | 26.52 | -- | -- | 18.27 |
| FCF CAGR (3Y) %i | -9.19 | 16.16 | -- | 17.25 | 38.23 | -- | 34.90 | -3.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 22.00 | 27.21 | 28.21 | 26.44 | 25.37 | 22.41 |
| ROA %i | 9.29 | 11.48 | 14.40 | 13.83 | 11.67 | 10.44 |
| ROIC %i | 14.04 | 17.66 | 19.93 | 19.36 | 19.73 | 18.73 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.27 | 16.36 | 17.89 | 18.05 | 15.83 | 13.62 |
| FCF / sales %i | 13.36 | 14.14 | 14.84 | 13.89 | 11.60 | 10.88 |
| Current ratioi | 0.74 | 0.66 | 0.71 | 0.67 | 0.90 | 0.79 |
| Quick ratioi | 0.50 | 0.45 | 0.46 | 0.39 | 0.42 | 0.37 |
| Debt / assetsi | 15.32 | 12.85 | 8.95 | 9.09 | 7.55 | 1.00 |
| LT debt / equityi | 25.53 | 3.26 | 2.60 | 2.55 | 2.50 | 1.50 |
| Interest coveragei | 27.83 | -- | -- | -- | 65.11 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Ryanair Designated Activity Company (DAC) is the largest reported line at 103.90% of revenue, across 3 reported segments.
- The next-largest line, Other Airlines, is a distant second at 10.29% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Ryanair Designated Activity Company (DAC)103.90%
Other Airlines10.29%
Quote time 2026-10-08 05:49:59 · For reference only, not investment advice and not tailored to your situation.